244 related articles for article (PubMed ID: 33075504)
1. Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study.
Wei L; Cheng X; Luo Y; Yang R; Lei Z; Jiang H; Chen L
Diabetes Metab; 2021 May; 47(3):101200. PubMed ID: 33075504
[TBL] [Abstract][Full Text] [Related]
2. Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study.
Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
Eur J Endocrinol; 2019 Aug; 181(2):185-192. PubMed ID: 31176297
[TBL] [Abstract][Full Text] [Related]
3. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
4. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis.
Gao Y; Zhao T; Song S; Duo Y; Gao J; Yuan T; Zhao W
Diabetes Res Clin Pract; 2023 Jun; 200():110699. PubMed ID: 37169306
[TBL] [Abstract][Full Text] [Related]
5. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
6. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
8. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
9. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
Sung KC; Seo DC; Lee SJ; Lee MY; Wild SH; Byrne CD
Nutr Metab Cardiovasc Dis; 2019 May; 29(5):489-495. PubMed ID: 30940491
[TBL] [Abstract][Full Text] [Related]
10. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes.
Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
Eur J Epidemiol; 2023 Aug; 38(8):901-911. PubMed ID: 37253998
[TBL] [Abstract][Full Text] [Related]
12. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka.
Niriella MA; Kasturiratne A; Pathmeswaran A; De Silva ST; Perera KR; Subasinghe SKCE; Kodisinghe SK; Piyaratna TACL; Vithiya K; Dassanayaka AS; De Silva AP; Wickramasinghe AR; Takeuchi F; Kato N; de Silva HJ
Hepatol Int; 2019 May; 13(3):314-322. PubMed ID: 30539516
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes.
Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
Liver Int; 2023 Nov; 43(11):2445-2454. PubMed ID: 37387519
[TBL] [Abstract][Full Text] [Related]
14. Adherence to a vegetable dietary pattern attenuates the risk of non-alcoholic fatty liver disease in incident type 2 diabetes: The TCLSIH cohort study.
Xia Y; Cao L; Zhang Q; Liu L; Zhang S; Meng G; Wu H; Gu Y; Sun S; Wang X; Zhou M; Jia Q; Song K; Wu Q; Niu K; Zhao Y
J Intern Med; 2022 Apr; 291(4):469-480. PubMed ID: 34875127
[TBL] [Abstract][Full Text] [Related]
15. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
[TBL] [Abstract][Full Text] [Related]
16. Long working hours and increased risks of lean non-alcoholic fatty liver disease among Korean men and women.
Lim GY; Chang Y; Kim I; Ryu S; Kwon R; Song J
Sci Rep; 2023 Jul; 13(1):12230. PubMed ID: 37507409
[TBL] [Abstract][Full Text] [Related]
17. The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study.
Bae JC; Han JM; Cho JH; Kwon H; Park SE; Park CY; Lee WY; Oh KW; Kwon S; Park SW; Rhee EJ
Diabetes Res Clin Pract; 2018 Jan; 135():1-6. PubMed ID: 29111276
[TBL] [Abstract][Full Text] [Related]
18. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Younes R; Govaere O; Petta S; Miele L; Tiniakos D; Burt A; David E; Vecchio FM; Maggioni M; Cabibi D; McLeod D; Pareja MJ; Fracanzani AL; Aller R; Rosso C; Ampuero J; Gallego-Durán R; Armandi A; Caviglia GP; Zaki MYW; Liguori A; Francione P; Pennisi G; Grieco A; Birolo G; Fariselli P; Eslam M; Valenti L; George J; Romero-Gómez M; Anstee QM; Bugianesi E
Gut; 2022 Feb; 71(2):382-390. PubMed ID: 33541866
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity.
Sinha N; Mukhopadhyay S; Sau M
Indian J Gastroenterol; 2020 Feb; 39(1):75-83. PubMed ID: 32314167
[TBL] [Abstract][Full Text] [Related]
20. Gender Differences in the Risk for Incident Non-Alcoholic Fatty Liver Disease According to the Transition of Abdominal Obesity Status: A 16-Year Cohort Study.
Lee JH; Jeon S; Lee HS; Kwon YJ
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
